In vitro activity of fosfomycin tromethamine and linezolid against vancomycin-resistant Enterococcus faecium isolates

International Journal of Antimicrobial Agents

Volumn 31, Issue 3, 2008, Pages 297-298

  Cilli, Feriha ^a   Pullukcu, Husnu ^a   Aydemir, Sohret ^a   Sipahi, Oguz Resat ^a   Tasbakan, Meltem ^a   Turhan, Ajda ^a   Ulusoy, Sercan ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAMIDES; CROSS INFECTION; ENTEROCOCCUS FAECIUM; FOSFOMYCIN; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; OXAZOLIDINONES; VANCOMYCIN RESISTANCE;

EID: 39149133144     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.11.003     Document Type: Letter

References (7)

1. Reis A.O., Corderio J.C.R., Machado A.M.O., and Sader H.S. In vitro activity of linezolid tested against vancomycin-resistant enterococci isolated in Brazilian hospitals. Braz J Infect Dis 5 (2001) 243-251
2. Noskin G.A., Siddiqui F., Stosor V., Hacek D., and Peterson L.R. In vitro activities of linezolid against important Gram-positive bacterial pathogens including vancomycin-resistant enterococci. Antimicrob Agents Chemother 43 (1999) 2059-2062
3. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Sixteenth informational supplement. M100-S16. Wayne, PA: CLSI; 2006.
4. Shrestha N.K., Chua J.D., Tuohy M.J., Wilson D.A., Procop G.W., Longworth D.L., et al. Antimicrobial susceptibility of vancomycin-resistant Enterococcus faecium: potential utility of fosfomycin. Scand J Infect Dis 35 (2003) 12-14
5. Murray B.E. Vancomycin-resistant enterococcal infections. N Engl J Med 342 (2000) 710-721
6. Allerberger F., and Klare I. In-vitro activity of fosfomycin against vancomycin-resistant enterococci. J Antimicrob Chemother 43 (1999) 211-217
7. Perri M.B., Hersberger E., Ionescu M., Lauter C., and Zervos M.J. In vitro susceptibility of vancomycin-resistant enterococci (VRE) to fosfomycin. Diagn Microbiol Infect Dis 42 (2002) 269-271